000 01425 a2200409 4500
005 20250515103839.0
264 0 _c20080408
008 200804s 0 0 eng d
022 _a1460-9568
024 7 _a10.1111/j.1460-9568.2007.06018.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCrotty, S
245 0 0 _aNeuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease.
_h[electronic resource]
260 _bThe European journal of neuroscience
_cJan 2008
300 _a294-300 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAnimals
650 0 4 _aDisease Models, Animal
650 0 4 _aMale
650 0 4 _aNeuroprotective Agents
_xchemistry
650 0 4 _aOxidopamine
_xtoxicity
650 0 4 _aParkinson Disease, Secondary
_xchemically induced
650 0 4 _aPhosphatidylglycerols
_xchemistry
650 0 4 _aPhospholipids
_xchemistry
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
700 1 _aFitzgerald, P
700 1 _aTuohy, E
700 1 _aHarris, D M
700 1 _aFisher, A
700 1 _aMandel, A
700 1 _aBolton, A E
700 1 _aSullivan, A M
700 1 _aNolan, Y
773 0 _tThe European journal of neuroscience
_gvol. 27
_gno. 2
_gp. 294-300
856 4 0 _uhttps://doi.org/10.1111/j.1460-9568.2007.06018.x
_zAvailable from publisher's website
999 _c17699093
_d17699093